Evidence map›Paper›PMID 17159899›Full record

ArticleThe EMBO journal2007

The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis.

Lisa Osterloh, Björn von Eyss, Fabienne Schmit, Lena Rein, Denise Hübner, Birgit Samans, Stefanie Hauser, Stefan Gaubatz

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lisa OsterlohDepartment of Physiological Chemistry I, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany.
Björn von Eyss
Fabienne Schmit
Lena Rein
Denise Hübner
Birgit Samans
Stefanie Hauser
Stefan Gaubatz
University of Würzburg · DEPhilipps University of Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulated gene expression is critical for the proper timing of cell cycle transitions. Here we report that human LIN-9 has an important function in transcriptional regulation of G2/M genes. Depletion of LIN-9 by RNAi in human fibroblasts strongly impairs proliferation and delays progression from G2 to M. We identify a cluster of G2/M genes as direct targets of LIN-9. Activation of these genes is linked to an association between LIN-9 and B-MYB. Chromatin immunoprecipitation assays revealed binding of both LIN-9 and B-MYB to the promoters of G2/M regulated genes. Depletion of B-MYB recapitulated the biological outcome of LIN-9 knockdown, including impaired proliferation and reduced expression of G2/M genes. These data suggest a critical role for human LIN-9, together with B-MYB, in the activation of genes that are essential for progression into mitosis.

Indexed as

Cell DivisionG2 PhaseGene Expression RegulationMitosisTranscription, GeneticCell Cycle ProteinsDNA-Binding ProteinsDNA DamageFibroblastsHeLa CellsHumansMultigene FamilyNuclear ProteinsPromoter Regions, GeneticProtein Structure, TertiaryRNA InterferenceCell Cycle ProteinsDNA-Binding ProteinsLIN9 protein, humanMYBL2 protein, humanNuclear ProteinsTrans-ActivatorsTumor Suppressor Proteins

Identifiers

PMID17159899
PMCPMC1782375
OpenAlexW2045067678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.